KOC
MBIO icon

Koss-Olinger Consulting’s Mustang Bio MBIO Stock Holding History

Koss-Olinger Consulting’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,967
Closed -$23K – 249
2024
Q3 		$23K Hold
1,967
– – ﹤0.01% 275
2024
Q2 		$47K Buy
+1,967
New +$37.4K ﹤0.01% 260
2024
Q1 		– Sell
-1,927
Closed -$130K – 200
2023
Q4 		$130K Sell
1,927
-73
-4% -$5.79K 0.01% 302
2023
Q3 		$207K Hold
2,000
– – 0.03% 247
2023
Q2 		$621K Buy
+2,000
New +$502K 0.07% 120
2021
Q3 		– Sell
-133
Closed -$332K – 256
2021
Q2 		$332K Sell
133
-80
-38% -$196K 0.05% 178
2021
Q1 		$531K Buy
+213
New +$633K 0.09% 122

Other funds holding MBIO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Koss-Olinger Consulting's MBIO Position: Q4 2024 in Review

Koss-Olinger Consulting sold out of Mustang Bio (MBIO) in Q4 2024, closing a stake of 1,967 shares — an estimated $23K sold.

Koss-Olinger Consulting first reported a position in MBIO in Q1 2021 and held it in 7 quarters. The position peaked at $621K in Q2 2023. 30 funds tracked by Wall St. Rank hold MBIO as of Q4 2024.

  • Koss-Olinger Consulting reported no remaining Mustang Bio position as of Q4 2024 after selling out during the quarter.
  • Koss-Olinger Consulting sold 1,967 Mustang Bio shares in Q4 2024, an estimated $23K.
  • Koss-Olinger Consulting first reported a position in Mustang Bio in Q1 2021 and held it in 7 quarters.
  • Koss-Olinger Consulting's Mustang Bio position peaked at $621K in Q2 2023.
  • 30 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2024.

Based on Koss-Olinger Consulting's 13F filing for Q4 2024, filed 11 Feb 2025.